Gilead Sciences, Inc. (NASDAQ:GILD) announced encouraging results from the completed phase I of the single-arm ZUMA-3 study evaluating pipeline candidate KTE-X19, an...
The market had a difficult session to start the week on Monday, but a lot of stocks we follow did well, and there are some new ones that we’ve been spotting. Let’s take...
Some trade setups that I really like and my analysis on where the market is going from here, and managing risk and avoiding stocks like O:KBIO. In this video, I also cover SPX,...